Tamibarotene inhibit the accumulation of fibrocyte and alleviate renal fibrosis by IL-17A

Volume: 42, Issue: 1, Pages: 1173 - 1183
Published: Jan 1, 2020
Abstract
Renal fibrosis is a common pathological process in the progression of chronic kidney disease. Accumulating evidence suggests that interleukin-17A (IL‐17A) and fibrocytes play crucial roles in the pathogenesis of fibrosis. However, the role of IL-17A in the regulation of renal fibrocytes in renal fibrosis has rarely been reported. Here, we report that the plasma IL-17A level is increased in immunoglobulin A nephropathy (IgAN) patients and is...
Paper Details
Title
Tamibarotene inhibit the accumulation of fibrocyte and alleviate renal fibrosis by IL-17A
Published Date
Jan 1, 2020
Volume
42
Issue
1
Pages
1173 - 1183
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.